The Missing Piece – Why are we not funding these tests to reduce pregnancy risk? “If I had access to a test that could predict my risk for pre-eclampsia I could have prevented a life-threatening situation for me and for my baby” – Sarah, pre-eclampsia survivor. Sarah spent a week in hospital with dangerously high […]
The Missing Piece – Why are we not funding these tests to reduce pregnancy risk? Read More »
Significant delays in diagnostic funding means patients are missing out The path to Medicare funding for new diagnostic technology is a notoriously challenging one, and a recent publication has now quantified the significant delay in Australia’s health technology assessment pathways. The poster, presented at ISPOR—The Professional Society for Health Economics and Outcomes Research, a collaborative
Significant delays in diagnostic funding means patients are missing out Read More »
The Missing Piece – ovarian cancer It took over 2 years for access to testing that identified suitable treatment for newly diagnosed ovarian cancer patients, during which time 88 LIVES were lost and an estimated $319.1 MILLION in benefits were foregone. A universal provision offering fully funded genetic testing for all cancers would avoid delays and open up
The Missing Piece – ovarian cancer Read More »